V

Vividion Therapeutics. Inc.

158 employees

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.

Investor insights

Sectors invested in

Cancer biology1

Health Care1

Biotechnology1

Therapeutics1

Wellness1

Drug development1

CRISPR1

Drug discovery1

Functional genomics1

Funding rounds participated in

$18M sweet spot round size

Most of their 1 investments are in rounds between $17M and $17M

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Health Care

Therapeutics

Date founded

2017

Investments made

T

Tavros Therapeutics raised $18M on October 12, 2022

Investors: Vividion Therapeutics. Inc.

Funding rounds raised

Total raised

$135M

from 21 investors over 21 rounds

V

Vividion Therapeutics. Inc. raised $135M on February 24, 2021

Investors: Nextech Invest, Woodline Partners LP, Versant Ventures, RA Capital Management, L.P., Driehaus Capital Management LLC, T. Rowe Price, SoftBank Investment Advisers, Logos Global Management, LP and Surveyor Capital

V

Vividion Therapeutics. Inc. raised $82M on April 30, 2019

Investors: Nextech Invest, Cardinal Partners (CP), Casdin Capital, LLC, Celgene, Mirae Asset MAPS Global Investments Co., Ltd, Versant Ventures and ARCH Venture Partners

V

Vividion Therapeutics. Inc. raised $101M on March 5, 2018

Investors: Celgene

V

Vividion Therapeutics. Inc. raised $50M on February 2, 2017

Investors: Cardinal Partners (CP), Versant Ventures and ARCH Venture Partners

V

Vividion Therapeutics. Inc. raised $3.5M on April 11, 2016

Investors: Cardinal Partners (CP)